Clinical trials recruiting in Farmington, Utah
7
Recruiting trials
15
Conditions
Phase breakdown
Phase 2 4Phase 3 5
Conditions recruiting in Farmington, Utah
Recruiting trials in Farmington, Utah
- APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
- Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
- Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
- Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Common questions
How many clinical trials are recruiting in Farmington, Utah?
7 recruiting trials have at least one study site in Farmington, Utah.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.